A Qualitative Longitudinal Study of Post-Diagnosis HSV-2 Reactions Among Women
Clinical Trial for Investigational Treatment of Chronic Pain
Not Recruiting
18 years - 100 years
Female
Phase
N/A
1 Location
Brief description of study.
No Description Available
Detailed description of study
No Description Available
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Genital Herpes
Age:
18 years - 100 years
Gender: Female
Who can participate: Adults aged 18-65 with a diagnosis of chronic pain lasting at least six months are eligible. Participants must not have any other significant medical conditions that could interfere with the study results.
Study details: Participants will be randomly assigned to receive either the investigational treatment or a placebo. The study will involve regular assessments of pain levels, physical function, and overall health. A placebo is an inactive substance designed to mimic the investigational treatment.
Updated on
19 Feb 2024.
Study ID: 0906-65
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
